US Patent Issued to Hoffmann-La Roche on May 26 for "Heterocyclic monoacylglycerol lipase (MAGL) inhibitors" (Swiss, German, French Inventors)

ALEXANDRIA, Va., May 26 -- United States Patent no. 12,637,454, issued on May 26, was assigned to Hoffmann-La Roche Inc. (Little Falls, N.J.).

"Heterocyclic monoacylglycerol lipase (MAGL) inhibitors" was invented by Joerg Benz (Rheinfelden, Germany), Uwe Grether (Efringen-Kirchen, Germany), Benoit Hornsperger (Altkirch, France), Carsten Kroll (Basel, Switzerland), Bernd Kuhn (Reinach, Switzerland), Fionn O'Hara (Basel, Switzerland) and Hans Richter (Grenzach-Wyhlen, Germany).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention provides new heterocyclic compounds having the general formula (I)wherein R1 to R3 are as described herein, compositions including the compounds, processes of manufacturing the ...